Literature DB >> 21959981

MicroRNA cloning and sequencing in osteosarcoma cell lines: differential role of miR-93.

Luisa Montanini1, Lisa Lasagna, Valeria Barili, Søren Peter Jonstrup, Alba Murgia, Laura Pazzaglia, Amalia Conti, Chiara Novello, Jørgen Kjems, Roberto Perris, Maria Serena Benassi.   

Abstract

BACKGROUND: Studies show that abnormalities in non-coding genes can contribute to carcinogenesis; microRNA levels may modulate cancer growth and metastatic diffusion.
METHOD: MicroRNA libraries were built and sequenced from two osteosarcoma cell lines (MG-63 and 143B), which differ in proliferation and transmigration. By cloning and transfection, miR-93, expressed in both cell lines, was then investigated for its involvement in osteosarcoma progression.
RESULTS: Six of the 19 miRNA identified were expressed in both cell lines with higher expression levels of miR-93 in 143B and in primary osteosarcoma cultures compared to normal osteoblasts. Interestingly, levels of miR-93 were significantly higher in metastases from osteosarcoma than in paired primary tumours. When 143B and MG-63 were transfected with miR-93, clones appeared to respond differently to microRNA overexpression. Ectopic expression of miR-93 more significantly increased cell proliferation and invasivity in 143B than in MG-63 clones. Furthermore, increased mRNA and protein levels of E2F1, one of the potential miR-93 targets, were seen in osteosarcoma cellular clones and its involvement in 143B cell proliferation was confirmed by E2F1 silencing.
CONCLUSION: Although further studies are needed to evaluate miRNA involvement in osteosarcoma progression, miR-93 overexpression seems to play an important role in osteosarcoma cell growth and invasion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21959981     DOI: 10.1007/s13402-011-0059-z

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  46 in total

1.  microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2.

Authors:  Hao Zhang; Xiaobing Cai; Yang Wang; Hao Tang; Daki Tong; Fang Ji
Journal:  Oncol Rep       Date:  2010-11       Impact factor: 3.906

2.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

3.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.

Authors:  Stefan S Bielack; Beate Kempf-Bielack; Günter Delling; G Ulrich Exner; Silke Flege; Knut Helmke; Rainer Kotz; Mechthild Salzer-Kuntschik; Matthias Werner; Winfried Winkelmann; Andreas Zoubek; Heribert Jürgens; Kurt Winkler
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

Review 4.  A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.

Authors:  O A Kent; J T Mendell
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867

5.  A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Authors:  P Mathijs Voorhoeve; Carlos le Sage; Mariette Schrier; Ad J M Gillis; Hans Stoop; Remco Nagel; Ying-Poi Liu; Josyanne van Duijse; Jarno Drost; Alexander Griekspoor; Eitan Zlotorynski; Norikazu Yabuta; Gabriella De Vita; Hiroshi Nojima; Leendert H J Looijenga; Reuven Agami
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

6.  Extensive modulation of a set of microRNAs in primary glioblastoma.

Authors:  S A Ciafrè; S Galardi; A Mangiola; M Ferracin; C-G Liu; G Sabatino; M Negrini; G Maira; C M Croce; M G Farace
Journal:  Biochem Biophys Res Commun       Date:  2005-09-09       Impact factor: 3.575

7.  MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness.

Authors:  Cristina Evangelisti; Maria Carolina Florian; Isabella Massimi; Carlo Dominici; Giuseppe Giannini; Silvia Galardi; Maria Cristina Buè; Simone Massalini; Heather P McDowell; Elio Messi; Alberto Gulino; Maria Giulia Farace; Silvia Anna Ciafrè
Journal:  FASEB J       Date:  2009-08-27       Impact factor: 5.191

8.  MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines.

Authors:  M Crawford; E Brawner; K Batte; L Yu; M G Hunter; G A Otterson; G Nuovo; C B Marsh; S P Nana-Sinkam
Journal:  Biochem Biophys Res Commun       Date:  2008-07-03       Impact factor: 3.575

Review 9.  MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death.

Authors:  R Schickel; B Boyerinas; S-M Park; M E Peter
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

Review 10.  Molecular genetics of sarcomas: applications to diagnoses and therapy.

Authors:  Junya Toguchida; Tomitaka Nakayama
Journal:  Cancer Sci       Date:  2009-06-24       Impact factor: 6.716

View more
  15 in total

Review 1.  Review of microRNA in osteosarcoma and chondrosarcoma.

Authors:  Le Chang; Swati Shrestha; Greg LaChaud; Michelle A Scott; Aaron W James
Journal:  Med Oncol       Date:  2015-04-26       Impact factor: 3.064

2.  MicroRNA-93 Downregulation Ameliorates Cerebral Ischemic Injury Through the Nrf2/HO-1 Defense Pathway.

Authors:  Peng Wang; Xinyu Liang; Yijun Lu; Xingjian Zhao; Jia Liang
Journal:  Neurochem Res       Date:  2016-06-14       Impact factor: 3.996

3.  Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype.

Authors:  Jae Yun Lim; Sun Och Yoon; So-Young Seol; Soon Won Hong; Jong Won Kim; Seung Ho Choi; Ju-Seog Lee; Jae Yong Cho
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

4.  Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.

Authors:  Guo Li; Shuling Ren; Zhongwu Su; Chao Liu; Tengbo Deng; Donghai Huang; Yongquan Tian; Yuanzheng Qiu; Yong Liu
Journal:  Tumour Biol       Date:  2015-01-13

5.  miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells.

Authors:  Junjie Niu; Yibao Sun; Qiaoge Guo; Dongju Niu; Bo Liu
Journal:  Dis Markers       Date:  2016-09-29       Impact factor: 3.434

6.  MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether à go-go 1 expression.

Authors:  Xinyu Wu; Daixing Zhong; Quan Gao; Wenliang Zhai; Zhenqi Ding; Jin Wu
Journal:  Int J Med Sci       Date:  2013-04-03       Impact factor: 3.738

Review 7.  MicroRNA function and dysregulation in bone tumors: the evidence to date.

Authors:  Mary Nugent
Journal:  Cancer Manag Res       Date:  2014-01-07       Impact factor: 3.989

8.  miR-155 inhibitor reduces the proliferation and migration in osteosarcoma MG-63 cells.

Authors:  Huicheng Lv; Jun Guo; Siqin Li; Dianmin Jiang
Journal:  Exp Ther Med       Date:  2014-09-01       Impact factor: 2.447

9.  CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d.

Authors:  Hsiao-Chi Tsai; Hong-Lin Su; Chun-Yin Huang; Yi-Chin Fong; Chin-Jung Hsu; Chih-Hsin Tang
Journal:  Oncotarget       Date:  2014-06-15

10.  MiR-542-5p is a negative prognostic factor and promotes osteosarcoma tumorigenesis by targeting HUWE1.

Authors:  Dong-dong Cheng; Tao Yu; Tu Hu; Ming Yao; Cun-yi Fan; Qing-cheng Yang
Journal:  Oncotarget       Date:  2015-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.